期刊文献+

缺血后处理对鼠在体肺缺血-再灌注损伤炎症反应作用的实验研究 被引量:2

Effects of Ischemic Postconditioning on Inflammatory Response in Ischemia-Reperfusion Injury of Rat Lungs in Vivo
原文传递
导出
摘要 目的探讨缺血后处理对大鼠在体肺缺血-再灌注损伤中炎症反应的影响。方法将40只SD大鼠随机分成假手术组(S组)、缺血-再灌注30 min组(I/R-30组)、缺血-再灌注120 min组(I/R-120组)、缺血后处理30 min组(IPO-30)和缺血后处理120 min组(IPO-120),每组8只。S组完成左侧开胸手术操作,肺门过阻断带,但肺门未阻断;I/R组拉紧肺门阻断带阻断左肺门,造成左肺缺血1 h,然后松开阻断带再灌注30 min和120 min(即I/R-30组和I/R-120组);IPO组在1 h的缺血之后再灌注开始前先进行10 s的缺血及10 s的再灌注(共3个循环,持续1 min),然后是与I/R组同样的30 min和120 min的长时间持续灌注(即IPO-30组和IPO-120组)。测定各组肺组织中白细胞介素10(IL-10)及血浆可溶性细胞间粘附分子1(sICAM-1)的水平。观察肺组织的病理形态变化并进行弥漫性肺泡损伤(DAD)评分。结果 I/R-30组和I/R-120组血浆中sICAM-1水平比S组显著升高[(2.140±0.250)μg/L vs(.0.944±0.188)μg/L,P=0.003;(2.191±0.230)μg/L vs(.0.944±0.188)μg/L,P=0.003],肺组织中IL-10水平亦明显高于S组[(15.922±0.606)pg/mg pro vs.(7.261±0.877)pg/mg pro,P=0.037;(17.421±1.232)pg/mg pro vs.(7.261±0.877)pg/mg pro,P=0.042],组织损伤明显。缺血后处理干预后,IPO-30组和IPO-120组血浆sICAM-1水平与相应I/R组各时间点相比显著降低[(1.501±0.188)μg/L vs(.2.140±0.250)μg/L,P=0.038;(1.350±0.295)μg/L vs(.2.191±0.230)μg/L,P=0.005],而IL-10水平显著升高[(20.950±1.673)pg/mg pro vs.(15.922±0.606)pg/mg pro,P=0.008;(25.334±1.173)pg/mg pro vs.(17.421±1.232)pg/mg pro,P=0.006],DAD评分显著降低[6.8±1.4 vs.11.5±1.9,P=0.007;7.5±1.6 vs.13.2±1.7,P=0.005],肺组织损伤较I/R组显著减轻。结论缺血后处理可能通过抑制炎症反应从而减轻肺缺血-再灌注损伤。 Objective To investigate the effects of ischemic postconditioning (IPO) on inflammatory response inischemia-reperfusion (IR) injury of rat lungs in vivo. Methods Forty SD rats were randomly divided into 5 groups inclu-ding a sham surgery group (S group),a 30-minute IR group (I/R-30 group),a 120-minute IR group(IR-120 group),a 30-minute IPO group (IPO-30 group),and a 120-minute IPO group (IPO-120 group). There were 8 rats in each group. All therats received left thoracotomy after anesthesia. In the sham surgery group,a line was only placed around the left hilum butnot fastened. In the I/R-30 group and I/R-120 group,a line was fastened to block the blood flow of the left lung for 1 hour,then loosened for reperfusion for 30 minutes and 120 minutes respectively. In the IPO-30 group and IPO-120 group,afterblocking the blood flow of the left lung for 1 hour,the left hilum was fastened for 10 seconds and loosened for 10 seconds(repeating 3 times for 1 minute),then the line was loosened for 30 minutes and 120 minutes respectively. The levels of interleukin-10 (IL-10) in lung tissues and soluble intercellular adhesion molecule-1 (sICAM-1) in plasma were measured. Histopathological changes of lung tissues were observed and diffuse alveolar damage (DAD) scores was calculated.Results The levels of plasma sICAM-1 in the I/R-30 group and I/R-120 group were significantly higher than that of S group [(2.140±0.250)μg/L vs. (0.944±0.188)μg/L,P=0.003;(2.191±0.230)μg/L vs. (0.944±0.188)μg/L,P=0.003]. IL-10levels in lung tissues in the I/R-30group and I/R-120 group were also significantly higher than that of S group[(15.922±0.606)pg/mg pro vs. (7.261±0.877)pg/mg pro,P=0.037;(17.421±1.232)pg/mg pro vs. (7.261±0.877)pg/mg pro,P=0.042]. Pathologic lesions of lung tissues in the I/R-30 group and I/R-120 group were more severe than that of S group. After IPO, plasma sICAM-1 levels in the IPO-30 group and IPO-120 group were significantly lower than those in the I/R-30group and I/R-120 group respectively [(1.501±0.188)μg/L vs.(2.140±0.250)μg/L,P=0.038;(1.350±0.295)μg/L vs.(2.191±0.230)μg/L,P=0.005]. IL-10 levels in lung tissues in the IPO-30 group and IPO-120 group were significantly higherthan those in the I/R-30 group and I/R-120 group respectively [(20.950±1.673)pg/mg pro vs.(15.922±0.606)pg/mgpro,P=0.008;(25.334±1.173)pg/mg pro vs.(17.421±1.232)pg/mg pro,P=0.006]. DAD scores in the IPO-30 group andIPO-120 group were significantly lower than those in the I/R-30 group and I/R-120 group respectively [6.8±1.4 vs. 11.5±1.9,P=0.007;7.5±1.6 vs. 13.2±1.7,P=0.005]. Pathological lesions of the lung tissues of IPO groups were less severe than those of I/R groups. Conclusion IPO can attenuate IR injury by inhibiting inflammatory response in rat lungs.
出处 《中国胸心血管外科临床杂志》 CAS 2013年第6期705-709,共5页 Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
基金 福建省医学创新课题(2009-CXB-62) 汕头市重点科技计划项目(汕府科[2010]63号)~~
关键词 缺血-再灌注损伤 缺血后处理 白细胞介素-10 可溶性细胞间粘附分子-1 Ischemia-reperfusion injury Ischemic postconditioning Interleukin-10 Soluble intercelleur adhension moleucule-1
  • 相关文献

参考文献8

二级参考文献88

共引文献106

同被引文献18

  • 1王继武,段明科,马立明.缺血后处理对肺再灌注损伤中脂质过氧化反应的调整[J].中国临床康复,2005,9(23):102-103. 被引量:14
  • 2Vinten-Johansen J, Shi W. Perconditioning and postconditioning: current knowledge, knowledge gaps, barriers to adoption, and fhture directions [ J ]. J Cardiovasc Pharmacol Ther, 2011, 16 : 260 -266.
  • 3Hariharan N, Zhai P, Sadoshima J. Oxidative stress stimulates autophagic flux during ischemia/reperfusion [ J ] . Antioxidants Redox Signal, 2011, 14: 2179-2190.
  • 4Pirat A, Zeynelogh P, Aldemir D, et al. Pretreatment with simvastatin reduces lung injury related to intestinal ischemia- reperfusion in rats[ J]. Anesth Analg, 2006, 102: 225-232.
  • 5Klionsky D J, Abdalla FC, Abeliovich H, et al. Guidelines for the use and interpretation of assays for monitoring autophagy [ J ]. Autophagy, 2012, 8 : 445-544.
  • 6Shanware NP, Bray K, Abraham RT. The PI3K, Metabolic, and autophagy networks: interactive partners in cellular health and disease[ J]. Annu Rev Pharmacol Toxicol, 2013, 53: 89-106.
  • 7Yu L, McPhee CK, Zheng L, et al. Termination of autophagy and reformation of lysosomes regulated by roTOR[ J ]. Nature, 2010, 465 : 942-946.
  • 8Prasad SS, Russell M, Nowakowska M. Neuroprotection induced in vitro by ischemie preconditioning and postconditioning : modulation of apoptosis and PI3K-Akt pathways [ J ] . J Mol Neurosci, 2011, 43: 428-442.
  • 9Yuan Y, Guo Q, Ye Z, et al. Ischemic postconditioning protects brain from ischemia/reperfusion injury by attenuating endoplasmic reticulum stress-induced apoptosis through PI3K-Akt pathway[ J ]. Brain Res, 2011, 1367 : 85-93.
  • 10Mahfoudh-Boussaid A, Zaouali MA, Hauet T, et al. Attenuation of endoplasmic reticulum stress and mitochondrial injury in kidney with ischemic postconditioning application and trimetazidine treatment[J]. J Biomed Sci, 2012, 19: 71.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部